Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 13, 2026
Total Value: $2.212B (98.7% shares, 1.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TRAX | FIRST TRACKS BIOTHERAPEUTICS | 2,032,012 | $40.88M | 1.8% | $20.12 | — | ORD SHS | 337185102 |
| MRNA | MODERNA INC | 500,000 | $35.02M | 1.6% | — | — | PUT | 60770K107 |
| ARKG | ARK ETF TR | 750,000 | $31.55M | 1.4% | — | — | CALL | 00214Q302 |
| LLY | ELI LILLY & CO | 20,000 | $23.99M | 1.1% | — | — | CALL | 532457108 |
| IDYA | IDEAYA BIOSCIENCES INC | 400,000 | $14.91M | 0.7% | $37.27 | — | COM | 45166A102 |
| ODTX | ODYSSEY THERAPEUTICS INC | 766,346 | $14.34M | 0.6% | $18.71 | — | COMMON STOCK | 67613T104 |
| OMER | OMEROS CORP | 1,411,300 | $13.42M | 0.6% | — | — | PUT | 682143102 |
| ALKS | ALKERMES PLC | 250,000 | $13.1M | 0.6% | $27.82 | — | CALL | G01767105 |
| QURE | UNIQURE NV | 175,000 | $8.06M | 0.4% | $46.06 | — | SHS | N90064101 |
| ASND | ASCENDIS PHARMA A/S | 30,000 | $8.002M | 0.4% | $266.72 | — | ORD SHS | K08588103 |
| EVMN | EVOMMUNE INC | 500,100 | $6.646M | 0.3% | — | — | PUT | 30054Y107 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 190,000 | $5.221M | 0.2% | $27.48 | — | COM NEW | 045396207 |
| COAG | HEMAB THERAPEUTICS HLDGS INC | 138,030 | $5.07M | 0.2% | $36.73 | — | COM SHS | 423494103 |
| RACC | RESEARCH ALLIANCE CORP III | 370,000 | $3.959M | 0.2% | $10.70 | — | ORD SHS CL A | G75226103 |
| AMAN | AMANAT ACQUISITION CORP | 375,000 | $3.81M | 0.2% | $10.16 | — | CL A ORD | G0375M101 |
| BHVN | BIOHAVEN LTD | 250,000 | $3.72M | 0.2% | $14.88 | — | COM | G1110E107 |
| SNSE | FAETH THERAPEUTICS INC | 144,404 | $3.61M | 0.2% | $25.00 | — | COM NEW | 81728A207 |
| — | CELCUITY INC | 2,000,000 | $2.283M | 0.1% | $1.14 | — | NOTE 0.250% 8/0 | 15102KAB6 |
| JATT | JATT II ACQUISITION CORP | 200,000 | $2.272M | 0.1% | $11.36 | — | ORD SHS | G50765109 |
| NMRA | NEUMORA THERAPEUTICS INC. | 1,070,651 | $1.82M | 0.1% | $1.70 | — | COM | 640979100 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 98,999 | $1.778M | 0.1% | $17.96 | — | COM | 03237H101 |
| SPRB | SPRUCE BIOSCIENCES INC | 30,000 | $1.62M | 0.1% | $54.00 | — | COM NEW | 85209E208 |
| SMMT | SUMMIT THERAPEUTICS INC | 100,000 | $1.457M | 0.1% | — | — | CALL | 86627T108 |
| EIKN | EIKON THERAPEUTICS INC | 98,001 | $1.279M | 0.1% | $13.05 | — | COM | 282564103 |
| ENGN | ENGENE THERAPEUTICS INC | 600,000 | $1.038M | 0.0% | $1.73 | — | COM | 29286X101 |
| BOLD | BOUNDLESS BIO INC | 250,000 | $625K | 0.0% | $2.50 | — | COM | 10170A100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 3,750,000 (+33.9%) | $133M (+71.1%) | 6.0% | $23.27 | — | SHS | G76279101 |
| RVMD | REVOLUTION MEDICINES INC | 250,000 (+150.0%) | $46.82M (+381.4%) | 2.1% | $128.03 | — | COM | 76155X100 |
| AVTX | AVALO THERAPEUTICS INC | 2,900,000 (+116.3%) | $53.59M (+167.7%) | 2.4% | $15.07 | — | COM NEW | 05338F306 |
| ORKA | ORUKA THERAPEUTICS INC | 590,000 (+18.1%) | $56.15M (+129.1%) | 2.5% | $32.86 | — | COM | 687604108 |
| RLAY | RELAY THERAPEUTICS INC | 1,050,000 (+162.5%) | $19.65M (+393.6%) | 0.9% | $14.75 | — | COM | 75943R102 |
| BLTE | BELITE BIO INC | 165,000 (+153.8%) | $25.41M (+145.2%) | 1.1% | $156.20 | — | SPONSORED ADS | 07782B104 |
| SGMT | SAGIMET BIOSCIENCES INC | 2,497,864 (+187.8%) | $19.31M (+325.7%) | 0.9% | $7.64 | — | COM SER A | 786700104 |
| STRO | SUTRO BIOPHARMA INC | 1,172,487 (+9.6%) | $38.93M (+46.1%) | 1.8% | $13.10 | — | COM SHS | 869367201 |
| ANRO | ALTO NEUROSCIENCE INC | 850,000 (+70.0%) | $22.43M (+99.6%) | 1.0% | $20.73 | — | COM SHS | 02157Q109 |
| EQ | EQUILLIUM INC | 4,100,000 (+234.3%) | $13.12M (+434.9%) | 0.6% | $2.67 | — | COM | 29446K106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 700,000 (+40.0%) | $26.05M (+64.2%) | 1.2% | $27.89 | — | COM NEW | 15117B202 |
| JBIO | JADE BIOSCIENCES INC | 840,350 (+31.3%) | $18.67M (+107.7%) | 0.8% | $15.73 | — | COM NEW | 008064206 |
| DNTH | DIANTHUS THERAPEUTICS INC | 400,000 (+14.3%) | $38.99M (+32.8%) | 1.8% | $47.49 | — | COM | 252828108 |
| INSM | INSMED INC | 650,000 (+35.4%) | $69.3M (-11.7%) | 3.1% | $85.42 | — | COM PAR $.01 | 457669307 |
| CLYM | CLIMB BIO INC | 972,000 (+38.9%) | $12.67M (+164.3%) | 0.6% | $6.03 | — | COM | 28658R106 |
| MANE | VERADERMICS INC | 100,000 (+42.9%) | $12.29M (+178.1%) | 0.6% | $81.09 | — | COMMON STOCK | 922967104 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,750,000 (+75.0%) | $11.92M (+166.6%) | 0.5% | $4.62 | — | COM SHS | 877619106 |
| PRAX | PRAXIS PRECISION MEDICINES I | 185,000 (+8.8%) | $61.94M (+13.1%) | 2.8% | $198.27 | — | COM NEW | 74006W207 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 148,013 (+48.0%) | $12.7M (+123.7%) | 0.6% | $64.13 | — | COM | G31249108 |
| PRQR | PROQR THRAPEUTICS N V | 5,543,936 (+125.9%) | $10.31M (+159.4%) | 0.5% | $2.33 | — | SHS EURO | N71542109 |
| — | COGENT BIOSCIENCES INC | 11,000,000 (+57.1%) | $13.65M (+59.0%) | 0.6% | $1.23 | — | NOTE 1.625%11/1 | 19240QAA0 |
| CGEM | CULLINAN THERAPEUTICS INC | 875,760 (+12.1%) | $15.95M (+43.6%) | 0.7% | $10.02 | — | COM | 230031106 |
| MGNX | MACROGENICS INC | 1,216,606 (+143.3%) | $5.621M (+289.0%) | 0.3% | $3.37 | — | COM | 556099109 |
| SABS | SAB BIOTHERAPEUTICS INC | 1,525,000 (+165.2%) | $5.947M (+170.1%) | 0.3% | $3.94 | — | COM NEW | 78397T202 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 84,900 (+142.6%) | $6.294M (+127.0%) | 0.3% | $70.95 | — | SHS NEW | M8694L137 |
| GENB | GENERATE BIOMEDICINES INC | 400,000 (+14.3%) | $6.748M (+54.2%) | 0.3% | $13.05 | — | COM SHS | 370920100 |
| ALEC | ALECTOR INC | 1,510,000 (+202.0%) | $3.035M (+182.3%) | 0.1% | $1.98 | — | COM | 014442107 |
| LXEO | LEXEO THERAPEUTICS INC | 5,807,611 (+15.0%) | $27.03M (-6.7%) | 1.2% | $5.12 | — | COM | 52886X107 |
| FBRX | FORTE BIOSCIENCES INC | 1,145,391 (+13.2%) | $24.34M (-7.1%) | 1.1% | $18.20 | — | COM NEW | 34962G208 |
| DTIL | PRECISION BIOSCIENCES INC | 646,576 (+8.1%) | $5.082M (+54.5%) | 0.2% | $4.29 | — | COM NEW | 74019P207 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 4,214,582 (+33.2%) | $14.37M (+8.9%) | 0.6% | $3.99 | — | COM NEW | 46489V302 |
| IBIO | IBIO INC | 4,007,881 (+29.0%) | $7.014M (+18.8%) | 0.3% | $1.70 | — | COM NEW | 451033708 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,650,000 (+3.8%) | $10.91M (-5.2%) | 0.5% | $7.77 | — | COM | 29842P105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | STATE STR SPDR S&P 500 ETF T | 200,000 | $130M | 5.9% | — | — | PUT | 78462F103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,400,000 | $55.61M | 2.5% | $27.87 | — | — | 152309100 |
| ACLX | ARCELLX INC | 362,764 | $41.65M | 1.9% | $46.50 | — | — | 03940C100 |
| TERN | TERNS PHARMACEUTICALS INC | 562,631 | $29.66M | 1.3% | $23.43 | — | — | 880881107 |
| ASND | ASCENDIS PHARMA A/S | 95,000 | $21.73M | 1.0% | $223.84 | — | — | 04351P101 |
| BMY | BRISTOL-MYERS SQUIBB CO | 300,000 | $18.2M | 0.8% | — | — | CALL | 110122108 |
| BBIO | BRIDGEBIO PHARMA INC | 150,000 | $11.14M | 0.5% | $58.10 | — | — | 10806X102 |
| WVE | WAVE LIFE SCIENCES LTD | 1,401,727 | $10.16M | 0.5% | $7.78 | — | — | Y95308105 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $9.725M | 0.4% | $128.03 | — | PUT | 76155X100 |
| IBRX | IMMUNITYBIO INC | 1,250,000 | $9.588M | 0.4% | — | — | PUT | 45256X103 |
| — | CELCUITY INC | 3,000,000 | $7.314M | 0.3% | $1.33 | — | — | 15102KAA8 |
| NVO | NOVO-NORDISK A S | 175,000 | $6.431M | 0.3% | — | — | CALL | 670100205 |
| DNTH | DIANTHUS THERAPEUTICS INC | 50,000 | $4.196M | 0.2% | $47.49 | — | CALL | 252828108 |
| ENGN | ENGENE HOLDINGS INC | 610,370 | $4.157M | 0.2% | $7.50 | — | — | 29286M105 |
| CGON | CG ONCOLOGY INC | 60,000 | $4.061M | 0.2% | — | — | CALL | 156944100 |
| CELC | CELCUITY INC | 30,000 | $3.424M | 0.2% | — | — | CALL | 15102K100 |
| CORT | CORCEPT THERAPEUTICS INC | 50,000 | $2.015M | 0.1% | $38.80 | — | — | 218352102 |
| KZR | KEZAR LIFE SCIENCES INC | 229,076 | $1.7M | 0.1% | $5.83 | — | — | 49372L209 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 374,000 (-73.3%) | $12.67M (-70.0%) | 0.6% | $8.35 | — | SPONSORED ADS | 881624209 |
| APGE | APOGEE THERAPEUTICS INC | 987,000 (-23.2%) | $131M (+21.1%) | 5.9% | $40.18 | — | COM | 03770N101 |
| COGT | COGENT BIOSCIENCES INC | 450,000 (-40.0%) | $17.41M (-39.7%) | 0.8% | $33.05 | — | COM | 19240Q201 |
| ALKS | ALKERMES PLC | 1,125,000 (-16.7%) | $58.94M (+23.5%) | 2.7% | $27.82 | — | SHS | G01767105 |
| TRVI | TREVI THERAPEUTICS INC | 1,800,172 (-10.0%) | $33.57M (+40.7%) | 1.5% | $5.69 | — | COM | 89532M101 |
| ERAS | ERASCA INC | 5,250,000 (-1.9%) | $96.18M (+11.1%) | 4.3% | $4.10 | — | COM | 29479A108 |
| MRNA | MODERNA INC | 475,000 (-40.6%) | $33.26M (-18.1%) | 1.5% | — | — | CALL | 60770K107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 40,000 (-27.3%) | $21.48M (-25.4%) | 1.0% | $336.27 | — | COM | 558868105 |
| ZURA | ZURA BIO LTD | 1,464,303 (-42.9%) | $8.639M (-43.4%) | 0.4% | $3.60 | — | CLASS A ORD SHS | G9TY5A101 |
| QURE | UNIQURE NV | 200,000 (-33.3%) | $9.212M (+87.8%) | 0.4% | $46.06 | — | CALL | N90064101 |
| OVID | OVID THERAPEUTICS INC | 10,144,562 (-4.6%) | $27.29M (+15.6%) | 1.2% | $1.37 | — | COM | 690469101 |
| ANAB | ANAPTYSBIO INC | 826,109 (-12.1%) | $55.76M (+7.0%) | 2.5% | $44.45 | — | COM | 032724106 |
| SGP | SPYGLASS PHARMA INC | 131,586 (-47.4%) | $2.929M (-54.8%) | 0.1% | $25.91 | — | COM SHS | 85220G109 |
| TYRA | TYRA BIOSCIENCES INC | 200,012 (-22.3%) | $6.388M (-35.2%) | 0.3% | $30.25 | — | COM | 90240B106 |
| NUVL | NUVALENT INC | 275,000 (-8.3%) | $33.96M (+10.5%) | 1.5% | $72.88 | — | COM | 670703107 |
| NXTC | NEXTCURE INC | 41,960 (-82.6%) | $67,136 (-97.4%) | 0.0% | $6.38 | — | COM NEW | 65343E207 |
| ELVN | ENLIVEN THERAPEUTICS INC | 500,000 (-14.8%) | $25.38M (+10.3%) | 1.1% | $25.60 | — | COM | 29337E102 |
| CMPS | COMPASS PATHWAYS PLC | 301,183 (-72.8%) | $4.262M (-30.5%) | 0.2% | $5.57 | — | SPONSORED ADS | 20451W101 |
| CRSP | CRISPR THERAPEUTICS AG | 100,000 (-33.3%) | $5.454M (-23.6%) | 0.2% | $53.50 | — | NAMEN AKT | H17182108 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 33,400 (-91.7%) | $144K (-91.6%) | 0.0% | $2.76 | — | COM | 68572M106 |
| XENE | XENON PHARMACEUTICALS INC | 1,595,000 (-4.8%) | $96.27M (-1.2%) | 4.4% | $39.93 | — | COM | 98420N105 |
| ABVX | ABIVAX SA | 330,000 (-18.5%) | $43.98M (-2.5%) | 2.0% | $83.67 | — | SPONSORED ADS | 00370M103 |
| CYTK | CYTOKINETICS INC | 550,000 (-21.5%) | $46.85M (+1.5%) | 2.1% | $53.01 | — | COM NEW | 23282W605 |
| ANL | ADLAI NORTYE LTD | 153,847 (-6.6%) | $1.769M (+55.2%) | 0.1% | $6.92 | — | SPONSORED ADS | 00704R109 |
| GLTO | DAMORA THERAPEUTICS INC | 425,000 (-5.6%) | $11.05M (-5.2%) | 0.5% | $25.80 | — | COM NEW | 36322Q206 |
| RZLT | REZOLUTE INC | 1,000,000 (-35.4%) | $5.2M (+10.2%) | 0.2% | $2.90 | — | COM NEW | 76200L309 |
| MBX | MBX BIOSCIENCES INC | 75,000 (-50.0%) | $4.14M (-7.5%) | 0.2% | $17.07 | — | COM | 55287L101 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 150,000 (-25.0%) | $12.23M (-2.5%) | 0.6% | $59.88 | — | COM | 04280A100 |
| AVBP | ARRIVENT BIOPHARMA INC | 125,000 (-28.6%) | $4.343M (+7.6%) | 0.2% | $20.99 | — | COM | 04272N102 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 312,500 (-37.5%) | $3.053M (+9.6%) | 0.1% | $6.12 | — | COM NEW | 48576U205 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 1,279,134 | $114M | 5.1% | $18.18 | — | COM NEW | 00773J202 |
| NRIX | NURIX THERAPEUTICS INC | 967,620 | $23.47M | 1.1% | $10.44 | — | COM | 67080M103 |
| TVTX | TRAVERE THERAPEUTICS INC | 300,000 | $17.04M | 0.8% | $19.81 | — | COM | 89422G107 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 912,397 | $8.987M | 0.4% | $5.53 | — | COM | 03675P102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 172,125 | $21.1M | 1.0% | $81.85 | — | COM | 74366E102 |
| SVRA | SAVARA INC | 2,512,153 | $15.47M | 0.7% | $3.81 | — | COM | 805111101 |
| IMVT | IMMUNOVANT INC | 100,000 | $3.853M | 0.2% | $16.19 | — | COM | 45258J102 |
| KRRO | KORRO BIO INC | 706,904 | $9.317M | 0.4% | $10.79 | — | COM | 500946108 |
| — | OMEROS CORP | 6,525,000 | $12.18M | 0.6% | $1.12 | — | NOTE 9.500% 6/1 | 682143AK8 |
| VERA | VERA THERAPEUTICS INC | 250,000 | $10.73M | 0.5% | $31.26 | — | CL A | 92337R101 |
| HLXC | HELIX ACQUISITION CORP III | 1,250,000 | $13.3M | 0.6% | $10.16 | — | USD CL A ORD SHS | G4444S107 |
| VRCA | VERRICA PHARMACEUTICALS INC | 707,338 | $4.329M | 0.2% | $5.54 | — | COM SHS | 92511W207 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 275,000 | $9.32M | 0.4% | $17.93 | — | ORDINARY SHARES | N62509109 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 245,000 | $5.343M | 0.2% | $6.02 | — | *W EXP 99/99/999 | N62509117 |
| LENZ | LENZ THERAPEUTICS INC | 100,000 | $568K | 0.0% | $15.73 | — | COM | 52635N103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 250,000 | $4.593M | 0.2% | $16.46 | — | COM | 92790C104 |
| QTTB | Q32 BIO INC | 27,777 | $354K | 0.0% | $13.78 | — | COM | 746964105 |
| OKUR | ONKURE THERAPEUTICS INC | 240,963 | $1.099M | 0.0% | $2.73 | — | COM CL A | 68277Q105 |
| OACCU | OAKTREE ACQUISITION CORP III | 250,000 | $2.75M | 0.1% | $10.15 | — | UNIT 10/04/2029 | G6717R120 |
| MLYS | MINERALYS THERAPEUTICS INC | 750,000 | $20.23M | 0.9% | $12.29 | — | COM | 603170101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 75,000 | $2.807M | 0.1% | $27.88 | — | COM | 22663K107 |
| XFOR | X4 PHARMACEUTICALS INC | 145,000 | $677K | 0.0% | $3.63 | — | COM NEW | 98420X202 |
| ADGM | ADAGIO MED HLDGS INC | 80,000 | $52,128 | 0.0% | $4.76 | — | COM | 00534B100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $278 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |